Search clinical trials for: Pelvic Radiotherapy

Total 8749 results

Sykehuset Telemark
Vestre Viken Hospital Trust; Oslo University Hospital; University Hospital of... and other collaborators

Not yet recruiting

Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors (PALLSOFT)

Gynecologic Cancer | Gastrointestinal Cancer | Urologic Cancer
European Institute of Oncology

Recruiting

Radiotherapy Treatments for Neoplasms in the Abdominal-pelvic Region

Abdominal Cancer | Pelvic Cancer

Italy
Fujian Cancer Hospital

Not yet recruiting

MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy

MRI | Cervical Cancer | Radiotherapy | Prognostic Model

China
University Medical Center Goettingen

Recruiting

Pelvic Cancer Registry for Online Adapted Radiotherapy (PRoART)

Pelvic Tumor | Thoracic Tumor

Germany
Fujian Cancer Hospital

Not yet recruiting

A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy

Cervical Cancer | Radiotherapy | Risk Factor | Prognostic Model | Distant Metastasis

China
Indiana University

Recruiting

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

Sexual Dysfunction | Pelvic Pain | Radiation Toxicity | Dyspareunia

United States
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Preoperative Radiotherapy And ASTX660 in Rectum Cancer (PRAAR1)

Locally-advanced Rectal Cancer

France
CHU de Quebec-Universite Laval
TerSera Therapeutics LLC

Recruiting

Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer. (PCS-XI)

Prostate Cancer | Radiotherapy Side Effect | Node; Prostate

Canada
JIN JING

Not yet recruiting

Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC（AK104-IIT-13） (AK104-IIT-13)

Locally Advanced Rectal Cancer
Washington University School of Medicine
Varian Medical Systems

Recruiting

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

Prostate Cancer | Cancer of the Prostate

United States
Peking Union Medical College Hospital
Peking University First Hospital; Xiangya Hospital of Central South University and other collaborators

Not yet recruiting

Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

Endometrial Cancer | Adjuvant Radiotherapy | Molecular Classification
MARILIA ALBANEZI BERTOLAZZI

Recruiting

Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment.

Locally Advanced Cervical Carcinoma | Premature Ovarian Failure

Brazil
McGill University Health Centre/Research Institute...

Not yet recruiting

Prospective Evaluation of Gastrointestinal and Genitourinary Side Effects of Pelvic Radiotherapy (PROs)

Radiotherapy Side Effects
University Health Network, Toronto

Recruiting

Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer (MOB-RT)

Prostate Cancer

Canada
Cairo University

Recruiting

Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer

Prostate Cancer

Egypt
Centre Hospitalier Departemental Vendee

Recruiting

Interest of Virtual Reality on Anxiety Before the Planning CT Scan in Radiotherapy (REAVA)

Breast Cancer | Pelvic Cancer

France
Leiden University Medical Center
Canadian Institutes of Health Research (CIHR); AstraZeneca; National Cancer Institute... and other collaborators

Recruiting

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO)

Endometrial Cancer

Netherlands, Canada, France, United Kingdom
University of Santo Tomas Hospital, Philippines
Philippine Council for Health Research & Development

Not yet recruiting

HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy (HYACINCT)

Locally Advanced Cervical Carcinoma
Shanghai Proton and Heavy Ion Center

Recruiting

Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases

Prostate Cancer

China
Ruijin Hospital

Recruiting

Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors Patients

Solid Tumor

China
Zhejiang Cancer Hospital

Recruiting

Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer (PAILACC)

Cervical Cancer

China
Peking University Third Hospital

Not yet recruiting

Adjuvant Radiotherapy in Patients With Early Endometrial Cancer

Endometrial Cancer | Radiotherapy | Pathology

China
Sixth Affiliated Hospital, Sun Yat-sen University

Not yet recruiting

Post Radiotherapy MRI Based AI System to Predict Radiation Proctitis for Pelvic Cancers (MRI-RP-2021)

Pelvic Cancer

China
University of Aarhus

Recruiting

Pencil Beam Proton Therapy for Pelvic Recurrences in Rectal Cancer Patients Previously Treated With Radiotherapy (ReRad II)

Rectal Cancer Recurrent

Denmark
University of Chicago

Recruiting

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

Endometrial Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Endometriosis | Cervical Carcinoma | Endometrial Carcinoma | Pelvic Inflammatory Disease

United States
University of Maryland, Baltimore

Recruiting

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Endometrial Cancer

United States
University of Maryland, Baltimore

Recruiting

Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)

Prostate Cancer | Prostate Adenocarcinoma

United States
Merck Sharp & Dohme LLC

Recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

Urinary Bladder Neoplasms

United States, Australia, Czechia, Estonia, France, Guatemala, Hungary, Israel, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Poland, Portugal, Puerto Rico, Romania, Spain, Taiwan, Turkey, Ukraine, United Kingdom, Denmark, ... and more
Columbia University

Recruiting

IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy

Abdominal Cancer | Pelvic Cancer

United States
Juergen Debus

Recruiting

Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy (DILANA)

Anal Cancer

Germany
National Institute of Cancerología

Recruiting

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer

Cervical Cancer

Mexico
Peking Union Medical College Hospital
Peking University First Hospital; Zhejiang Cancer Hospital; Xiangya Hospital... and other collaborators

Recruiting

Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer

Uterine Cervical Neoplasms

China
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting

Short Course Radiation Therapy in Palliative Treatment of Pelvic Cancer

Pelvic Cancer | Palliative Care | Radiotherapy

Italy
National Institute of Cancerología

Recruiting

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer

Cervix Cancer

Mexico
Loyola University

Recruiting

BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy (BEACON)

Prostate Cancer - Recurrent

United States
Centre Georges Francois Leclerc

Recruiting

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk (SHORT)

To Evaluate the Rate of Digestive and Urinary Toxicity

France
UNICANCER

Recruiting

Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30) (Bladder-ART)

Patients With High-risk MIBC

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy (PRISME)

Pelvic Radiation Therapy | Radiation-induced Hemorrhagic Cystitis

France
European Institute of Oncology
Associazione Italiana per la Ricerca sul Cancro

Recruiting

Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer

Adenocarcinoma of Prostate

Italy
Jules Bordet Institute

Completed

PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ) (PROCAR-BQ)

Quality of Life | Prostate Cancer | Radiotherapy Side Effect | Bowel Dysfunction

Belgium
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; Cancer and Leukemia Group B

Active, not recruiting

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Prostate Cancer

United States, Canada, China, Israel
UNICANCER
Sanofi

Active, not recruiting

A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse (PEACE2)

Adenocarcinoma of Prostate | Progression of Prostate Cancer

France
University Medical Center Groningen

Completed

Repeat CT Scans for Evaluation of Inter- and Intrafraction Motion and it's Effect on Radiotherapy Dose Distribution During Curative Radiotherapy for Pelvic Tumours (RACE)

Pelvic Tumor

Netherlands
Lawson Health Research Institute

Active, not recruiting

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

Carcinosarcoma | Endometrioid Adenocarcinoma | Clear Cell Carcinoma | Serous Carcinoma | Dedifferentiated Carcinoma

Canada
Merck Sharp & Dohme LLC
Astellas Pharma Inc; Seagen Inc.

Active, not recruiting

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304) (KEYNOTE-B15)

Bladder Cancer

Hungary, United States, China, Argentina, Australia, Bulgaria, Canada, Colombia, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Malaysia, Philippines, Poland, Portugal, Romania, Russian Federation, Singapo... and more
Institut de cancérologie Strasbourg Europe

Completed

Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation (MIFADORESOL)

Vaginal Cancer | Prostate Carcinoma | Radiotherapy | Rectum Carcinoma | Cervix Carcinoma | Anal Canal Carcinoma | Endometrium Carcinoma

France
UNICANCER
Ferring Pharmaceuticals

Active, not recruiting

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy (GETUG-AFU22)

Adenocarcinoma of Prostate

France
The Christie NHS Foundation Trust

Active, not recruiting

Bone Toxicity Following Pelvic Radiotherapy (RadBone)

Gynecologic Cancer | Radiotherapy Side Effect | Fracture

United Kingdom
Washington University School of Medicine
Goldman Sachs Foundation (Emerson Collective)

Completed

Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers

Sarcoma | Thoracic Cancer | Abdominal Cancer | Pelvic Cancer

United States

Search clinical trials for: Pelvic Radiotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations